Genetics and the placebo effect: the placebome

This publication has 97 references indexed in Scilit:

• Association of dopamine-related genetic loci to dopamine D3 receptor antagonist ABT-925 clinical response
  Translational Psychiatry, 2013
• Developing New Drug Treatments in the Era of Network Medicine
  Clinical Pharmacology & Therapeutics, 2012
• COMT Val158Met Genotype Determines the Direction of Cognitive Effects Produced by Catechol-O-Methyltransferase Inhibition
  Biological Psychiatry, 2012
• Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma
  New England Journal of Medicine, 2011
• Interactome Networks and Human Disease
  Cell, 2011
• Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine
  Psychiatric Genetics, 2010
• Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study
  Pharmacogenetics and Genomics, 2010
• Biological, clinical, and ethical advances of placebo effects
  The Lancet, 2010
• Association of Major Depressive Disorder with Serum Myeloperoxidase and Other Markers of Inflammation: A Twin Study
  Biological Psychiatry, 2008
• Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
  New England Journal of Medicine, 2008